No photo of Christopher Bowlus

View Scopus Profile

Christopher Bowlus, MD

Professor

  • 7988 Citations
  • 43 h-Index
1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Christopher Bowlus is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

SACRAMENTO COLLABORATIVE TO ADVANCE TESTING AND CARE OF HEPATITIS B (SCRATCH)

Bowlus, C.

National Institutes of Health

9/30/14 → 9/29/16

Project: Research project

An Open-Label Study of Ursolkc Acid for Primary Sclerosing Cholangitis

Bowlus, C.

National Institutes of Health

3/24/14 → 1/31/16

Project: Research project

    • Biologic Basis of Disparity in Liver Cancer Survival Among Asian Americans

    Bowlus, C.

    National Institutes of Health

    9/17/13 → 8/31/16

    Project: Research project

    • Oxidative mutagenesis:Iron, Ascorbic Acid and Genes

    Bowlus, C.

    National Institutes of Health

    9/15/01 → 8/31/03

    Project: Research project

    • CLONING OF THE HEMOCHROMATOSIS LOCUS

    Bowlus, C.

    National Institutes of Health

    8/9/96 → 6/30/01

    Project: Research project

    • Research Output

    Editorial: biochemical responses do not tell the whole story in primary biliary cholangitis

    Bowlus, C. L. & Levy, C., Jan 1 2020, In : Alimentary Pharmacology and Therapeutics. 51, 1, p. 177-178 2 p.

    Research output: Contribution to journal › Editorial

    Open Access

    Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases

    International Primary Sclerosing Cholangitis Study Group (IPSCSG), Jan 2020, In : Clinical Gastroenterology and Hepatology. 18, 1, p. 179-187.e6

    Research output: Contribution to journal › Article

    Open Access
    • 6 Scopus citations

    Statins, fibrates, and other peroxisome proliferator-activated receptor agonists for the treatment of cholestatic liver diseases

    Dubrovsky, A. M. K. & Bowlus, C. L., Jan 1 2020, In : Gastroenterology and Hepatology. 16, 1, p. 31-38 8 p.

    Research output: Contribution to journal › Article

    • Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis

    FOLD Investigators, Feb 1 2020, In : The American journal of gastroenterology. 115, 2, p. 262-270 9 p.

    Research output: Contribution to journal › Article

    • AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review

    Bowlus, C. L., Lim, J. K. & Lindor, K. D., Nov 2019, In : Clinical Gastroenterology and Hepatology. 17, 12, p. 2416-2422 7 p.

    Research output: Contribution to journal › Article

    • 3 Scopus citations